Ulanghutan, Muhammad Rhyadh T.

HRN: 26-53-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/30/2025
06/06/2025
IV
400mg
Q6
SSTIs
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: